Lv3
260 积分 2025-09-05 加入
A Review on Commercial Oligonucleotide Drug Products
1天前
待确认
The evolving role of investigative toxicology in the pharmaceutical industry
21天前
已完结
The U.S. wants to phase out animal research. Are the alternatives ready?
25天前
已完结
New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now?
25天前
已完结
Navigating Complexity in Modern Toxicology: The Role of Omics in Short-Term In Vivo Studies
25天前
已关闭
Liver organoid culture methods
1个月前
已完结
Points to consider for revising the ICH S7A guideline on safety and secondary pharmacology
1个月前
已完结
Click chemistry for targeted protein ubiquitylation and ubiquitin chain formation
1个月前
已完结
Antibody-drug conjugates: Principles and opportunities
1个月前
已完结
Gaps and challenges in nonclinical assessments of pharmaceuticals: An FDA/CDER perspective on considerations for development of new approach methodologies
1个月前
已完结
皖公网安备34019202002308
